Intravenous tenoxicam to treat acute renal colic: Comparison with buscopan compositum

Journal of the Pakistan Medical Association

Volumn 48, Issue 12, 1998, Pages 370-372

  Dawood Al Waili, Noori S ^a   Saloom, Kholood Y ^a  

^a DUBAI MEDICAL COLLEGE   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

PETHIDINE; SCOPOLAMINE BUTYL BROMIDE; TENOXICAM;

ADULT; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; INTRAVENOUS UROGRAPHY; KIDNEY COLIC; MALE; PAIN; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SCORING SYSTEM; URINALYSIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BUTYLSCOPOLAMMONIUM BROMIDE; COLIC; DIPYRONE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; HUMANS; KIDNEY DISEASES; PARASYMPATHOLYTICS; PIROXICAM; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 13044264454     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Al-Waili N. Clinical usefulness of nifedipine in acute and recurrent ureteric colic. Med. Sci. Res., 1988;16:1245-47.
2. Borglil L, Meschi T, Amato F. Nifedipine and methylprednisolone in facilitating ureteral stone passage: A randomized, double blind, placebo controlled study. J. Urol. 1994;152:1095-98.
3. Capecchl S, Pignatelli R, Alegiani F. Emergency treatment of ureteral colic with nifedipine. Minerva Urol. Nefrol., 1991;43:287-91.
4. Al-Waili N. Prostaglandin synthetase inhibition with indomethacin rectal suppositories in the treatment of acute and chronic urinary calculus obstruction. Clin. Exp. Pharm. Physiol., 1986;13:195-99.
5. Al-Waili N. Indomethacin suppositories to treat primary nocturnal frequency of micturation - IRCS. 1986;14:322-3Qi10.
6. Al-Waili N. Three cases of nephrotic syndrome treated by indomethacin. J. Pak. Med. Assoc., 1988;28:54-6.
7. Al-Waili N. Diclofenac sodium in the treatment of primary nocturnal enuresis; A double-blind cross-over study. Clin. Exp. Pharm. Physiol., 1986;13:139-42.
8. Al-Waili N. Indomethacin suppositories to treat primary nocturnal enuresis: A double-blind study. J. Urol., 1989;142:1290-2.
9. Al-Waili N. Piroxicain for acute renal colic. 30th Arab Medical Union Conference. Sanaa, Yemen, 15-17 July, 1997.
10. Sandhu D, Jacovu J. Fletcher M, et al. A comparison of intra- muscular ketorolac and pethidine in the alleviation of renal colic. Br. J. Urol., 1994;74:1690-3.
11. Margrimi M, Pavesi G, Liverta C, et al. Intravenous ketoprofen in renal colic: A placebo-controlled pilot study. Clin. Ther, 1984;6:483-7.
12. Al-Waili N. Intramusuclar tenoxicam to treat acute renal colic. Br. J. Urol., 1996;77:15-16.
13. Colli S, Colombo S, Trernoli E, et al. Effects of tenoxicam on superoxide anion formation, beta-glucuronidase release and fMLP binding in human neutrophils: Comparison with other NSAIDs. Pharmacol Res., 1991;23:367-79.
14. Jeunet F, Enz W, Guentert T. Tenoxicam used as parental formulation for acute pain in rheumatic conditions. Scand. J. Rheumatol., 1989;80(Suppl 1):59-61.
15. Lalos J, Tsachalos P, Gallis L. Long-term (four-years) Clinical trial with tenoxicam and basis therapy in patients suffering from rheumatoid arthritis. Scand. J. Pharmacol, 1989;80(suppl 1):67-70.
16. Van-Jaarsfeld C, Groenveld H. Evaluation of tenoxicam for control of post-operative pain and swelling following surgical removal of impacted molars. J. Dent. Assoc. S. Afr., 1991;46:575-8.
17. Al-Waili N. Intravenous tenoxicam to treat acute biliary colic, 30th Arab Medical Union Conference, Sanaa, Yemen, 15-17 July, 1997.
18. Al-Waili N. Intravenous tenoxicam, for post-operative pain, 30th Arab Medical Union Conference, Sanaa, Yemen, 15-17 July, 1997.
19. Holmlund D, Sjodim J. Treatment of ureteral colic with intravenous indomethacin. J. Urol. 1978;120:676-7.
20. Olsen U, Magnnussen M, Elertssen E. Prostaglandins, a link between hydro and haemodynamic in dog. Acta Physiol. Scand., 1976;97:369-76.
21. Johston H, Herzog J, Laurel D. Effects of Prostaglandins E2 on renal hemodynamic sodium and water excretion. Am. J. Physiol., 1967;213:939-46.
22. Holmulund D. Ureteral stones: An experimental and clinical study of the mechanism of passage of arrest of ureteral stones. Scand. J. Urol. Nephrol., 1968;(Suppl)1:1-80.
23. Tanaka Y, Himori N. Structure - activity relationship of the thienothiazine derivatives with their anti-inflammatory, analgesic and ulcerogenic effects and their inhibiting effects on PGF2 biosynthesis. Nippon, Yakurigaku, Zazzhi, 1989;94:61-71.
24. Vlak T, Jali I, Bill A. Comparative study of the occurrence of gastrointestinal side effects of tenoxicam and other nonsteroidal anti-rheumatic agents in patients with rheumatoid arthritis. Reumatizam, 1996;43:1-9.
25. Al-Quorain A, Satti B, Marwash S, et al. Non-steroidal anti- inflammatory drug-induced gastropathy: A comparative endoscopic and histopathological evaluation of effects of tenoxicam and diclofenac. Int. Med. Res., 1993;21:89-97.
26. Taglier G, Raffaele A, Aciteli L, et al. Evaluation of the anti-inflammatory effect and tolerability of tenoxicam in short-term treatment of osteoarthrosis in aged. Clin. Ter. 1992;140:243-9.
27. Todd A, Clissold P. Tenoxicam and update of its pharmacology and therapeutic efficacy in rheumatic diseases. Drugs, 1991;41:625-46.
28. Muriel-Villoria C, Zungri-Telo E. Comparison of the onset and duration of the analgesic effect of dipyrone, 1 or 2 g, by the intramuscular or intravenous route, in acute renal colic. Eur. J. Clin. Pharmacol., 1995;48:103-7.
29. Weithmann K, Alpermann G. Biochemical and pharmacological effects of dipyrone and its metabolites in model systems related to arachidonic acid cascade. Arzneimittelforschung, 1985;35:947-52.
30. Eldor A, Polliack G, Vlodaavsky I. Effects of dipyrone on prostaglandin production by human platelets and cultured bovine aortic endothelial cells. Thromb. Haemost., 1983;49:132-7.
31. Zwergel U, Zwergel T, Ziegler M. Effects of prostaglandins and prostaglandin synthetase inhibitors on acutely obstructed kidneys in the dog. Urol. Int., 1991;47:64-9.
32. Roelvink M, Goossens L, Kalsbeek C. Analgesic and spasmolytic effects of dipyrone, hyoscine N-butylbromide and a combination of the two in poies. Vet. Rec., 1991;129:378-80.
33. Temple G, von Hundelshausen B, Reeker W. The opiate-sparing effect of dipyrone in postoperative pain therapy with morphine using a patient-controlled analgesic system. Intensive Care Med., 1996;22:1043-7.
34. Bartoli E. Drug induced asthma, Lancet, 1976;1:1357-9.
35. Giamberardino M, Valente R, De-Bigontina P. Effects of spasmolytic and or non-steroidal anti-inflammatory drugs on muscle hyperalgesia of ureteral origin in rats. Eur. J. Pharmacol. 1995;278:97-101.
36. Gordon R. Allergic contact dermatitis caused by transdermal hy oscine. Br. Med. J., 1989;298:1220-1.